Healthcare -
Biotechnology - NASDAQ - GB
$ 0.53
-1.85 %
$ 22.6 M
Market Cap
-3.12
P/E
ADAP - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ADAP - Adaptimmune Therapeutics plc
880 K
LAST VALUE
-48.27%
2 YEAR CAGR
-61.40%
5 YEAR CAGR
-13.40%
10 YEAR CAGR